Trans fatty acids - A risk factor for cardiovascular disease

Pakistan Journal of Medical Sciences

Volumn 30, Issue 1, 2014, Pages 194-197

  Iqbal, Mohammad Perwaiz ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Cardiovascular disease; Coronary heart disease; Dietary fats; South Asia; Trans fatty acid

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANS FATTY ACID;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEATH; DENMARK; FAT INTAKE; GENETICALLY MODIFIED FOOD; HUMAN; HYDROGENATION; INTERESTERIFICATION; ISCHEMIC HEART DISEASE; PAKISTAN; POLICY; PREVALENCE; REVIEW; SOUTH ASIA; WORLD HEALTH ORGANIZATION; DIETARY REFERENCE INTAKE; FOOD CONTROL; MORTALITY; RISK ASSESSMENT; RISK REDUCTION; RUMINANT;

EID: 84892393370     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.301.4525     Document Type: Review

References (29)

1. Codex Alimentarius Commission. Joint FAO/WHO Food Standards Programme. Codex Committee on Food Labelling 2005; May 9-13, Kota Kinabala Malaysia [ftp. fao. org/codex/meetings/ccfl40_020. pdf].
2. Wanders AJ, Brouwer IA, Siebelink E, Katan MB. Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects. PLoS One. 2010; 5(2): e9000. doi: 10. 1371/journal. pone. 0009000.
3. Trans fat-Wikipedia, the free encyclopedia. [www. en. wikipedia. org/wiki/Trans_fat].
4. Sundram K, Basiron Y. Trans fatty acids-Nutritional considerations and lebeling: An update and implications for oils and fats industry. Seminar on Food and Micronutritional Aspects of Red Palm Oil. 2003; March 8, Karachi.
5. Chibber A. India to reduce trans fats in vanaspati oils. [www. foodnavigator-asia. com].
6. Ghafoorunissa G. Role of trans fatty acids in health and challenges to their reduction in Indian foods. Asia Pac J Clin Nutr. 2008; 17(1): 212-215.
7. Mozaffarian D, Abdollahi M, Campose H, Houshiarrad A, Willett WC. Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr. 2007; 61(8): 1004-1010.
8. Bhanger MI, Anwar F. Fatty acid (FA) composition and contents of trans unsaturated FA in hydrogenated vegetable oils and blended fats from Pakistan. JAOCS. 2004; 81(2): 129-134.
9. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990; 323(7): 439-445.
10. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993; 341(8845): 581-585.
11. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006; 354(15): 1601-1613.
12. Hu FB, Stampfer MJ, Manson JE, Rimm E, Coldtiz GA, Rosner BA, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997; 337(21): 1491-1499.
13. Ascherio A, Willett WC. Health effects of trans fatty acids. Am J Clin Nutr. 1997; 66(4 Suppl): 1006s-1010s.
14. Food and Agriculture Organization of the United Nations. Fat and Oils in Human Nutrition, Report of a Joint Expert Consultation. Food and Agriculture Organization of the United Nations and the World Health Organizations, Rome, October 19-26, 1993, Food and Nutrition Paper No. 57(1994).
15. Trans fat regulation. News-Medical. Net. 1 Jan 2008. [www. news-medical. net/health/Trans-Fat].
16. Stender S, Dyerberg J. Influence of trans fatty acids on health. Ann Nutr Metab. 2004; 48(2): 61-66.
17. Ahmad K. Facing up to Pakistan's cardiovascular challenge. Lancet. 2002; 359(9309): 859.
18. Mendis S, Cruz-Hernandez C, Ratnayake WM. Fatty acid profile of Canadian dairy products with special attention to the trans-octadecenoic acid and conjugated linoleic acid isomers. JAOAC Int. 2008; 91(4): 811-819.
19. Funck LG, Barrera-Arellano D, Block JM. Conjugated linoleic acid (CLA) and its relationship with cardiovascular disease and associated risk factors. Arch Latinoam Nutr. 2006; 56(2): 123-134.
20. Brouwer IA, Wanders AJ, Katan MB. Trans fatty acids and cardiovascular health: research completed? Eur J Clin Nutr. 2013; 67(5): 541-547.
21. Mozaffarian D, Jacobson MF. Food reformulations to reduce trans fatty acids. N Engl J Med 2010; 362: 2037-2039.
22. Food fats and oils. Institute of Shortening and Edible Oils. Technical Committee. Institute of Shortening and Edible Oils 2006-Oils and fats, Edible.
23. Baumgartner S, Mensink RP. Metabolic effects of interesterified dietary fat in humans: a literature review. 2008; [www. mvo. nl/./Reviews%20Mensink_interesterification% 20MVO. pd.].
24. Liu X, Sheng J. and Curtiss III R. Fatty acid production in genetically modified cyanobacteria. Proc Natl Acad Sci USA. 2011; 108(17): 6899-6904.
25. Iqbal MP. Economic development by reducing the burden of cardiovascular disease in South Asia. Pak J Med Sci. 2012; 28(3): 564-566.
26. Bhardwaj S, Passi SJ, Misra A. Overview of trans fatty acids: biochemistry and health effects. Diabetes Metab Syndr. 2011; 5(3): 161-164.
27. Mozaffarian DL. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003; 107: 1372-1377.
28. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, et al. n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006; 84: 5-17.
29. de Oliveira Otto MC, Mozaffarian D, Kromhout D, Bertoni AG, Sibley CT, Jacobs DR Jr, et al. Dietary intake of saturated fat by food source and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. Am J Clin Nutr. 2012; 96(2): 397-404.